Stock Research for ESPR


Featured Broker: Ally Invest

Get the due diligence for another stock.


ESPR Stock Chart & Research Data

The ESPR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ESPR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ESPR Due diligence Resources & Stock Charts

The ESPR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ESPR Detailed Price Forecast - CNN Money CNN View ESPR Detailed Summary - Google Finance
Yahoo View ESPR Detailed Summary - Yahoo! Finance Zacks View ESPR Stock Research & Analysis -

Stock Analysis

TradeIdeas View ESPR Trends & Analysis - Trade-Ideas Barrons View ESPR Major Holders - Barrons
NASDAQ View ESPR Call Transcripts - NASDAQ Seeking View ESPR Breaking News & Analysis - Seeking Alpha
Spotlight View ESPR Annual Report - OTC Report View ESPR OTC Short Report -
TradeKing View ESPR Fundamentals - TradeKing Charts View ESPR SEC Filings - Bar Chart
WSJ View Historical Prices for ESPR - The WSJ Morningstar View Performance/Total Return for ESPR - Morningstar
MarketWatch View the Analyst Estimates for ESPR - MarketWatch CNBC View the Earnings History for ESPR - CNBC
StockMarketWatch View the ESPR Earnings - StockMarketWatch MacroAxis View ESPR Buy or Sell Recommendations - MacroAxis
Bullish View the ESPR Bullish Patterns - American Bulls Short Pains View ESPR Short Pain Metrics -

Social Media Mentions

StockTwits View ESPR Stock Mentions - StockTwits PennyStocks View ESPR Stock Mentions - PennyStockTweets
Twitter View ESPR Stock Mentions - Twitter Invest Hub View ESPR Investment Forum News - Investor Hub
Yahoo View ESPR Stock Mentions - Yahoo! Message Board Seeking Alpha View ESPR Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ESPR - Insider Cow View Insider Transactions for ESPR - Insider Cow
CNBC View ESPR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ESPR - OTC Markets
Yahoo View Insider Transactions for ESPR - Yahoo! Finance NASDAQ View Institutional Holdings for ESPR - NASDAQ

Stock Charts

FinViz View ESPR Stock Insight & Charts - StockCharts View ESPR Investment Charts -
BarChart View ESPR Stock Overview & Charts - BarChart Trading View View ESPR User Generated Charts - Trading View

Latest Financial News for ESPR

For Esperion Therapeutics, 2019 Could Be a Big Year
Posted on Friday January 11, 2019

The developer of a new cholesterol-lowering treatment is on a path toward commercialization.

Update: Lawsuit for Investors in shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) announced by Shareholders Foundation
Posted on Monday January 07, 2019

SAN DIEGO, CA / ACCESSWIRE / January 7, 2019 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR ). Investors, ...

Daiichi Sankyo Europe Enters into European Licensing Agreement with Esperion for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet
Posted on Sunday January 06, 2019

MUNICH , January 7, 2019 /PRNewswire/ -- Daiichi Sankyo   Europe   will market   oral   bempedoic acid and   bempedoic acid   / ezetimibe combination   tablet   in   the   European Economic Area and   ...

All the Pre-JPM News Healthcare Investors Need to Know
Posted on Sunday January 06, 2019

The Super Bowl of biotech kicked off early for these companies.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.